Recent data show reciprocal changes in global methylation patterns between IPF and lung cancers and hypermethylation of the CD90/Thy-1 promoter region in IPF, contributing to the loss of the glycoprotein Thy-1, associated with invasive cancer behaviors and the transition from fibroblasts to myofibroblasts [27]. The gene discussed is THY1; the disease is cancer.